Literature DB >> 28426937

High-Throughput Quantitative Intrinsic Thiol Reactivity Evaluation Using a Fluorescence-Based Competitive Endpoint Assay.

Tomoya Sameshima1, Ikuo Miyahisa1, Seiji Yamasaki1, Mika Gotou1, Toshitake Kobayashi1, Junichi Sakamoto1.   

Abstract

In a high-throughput screening (HTS) process, the chemical reactivity of test samples should be carefully examined because such reactive compounds may lead to false-positive results and adverse effects in vivo. Among all natural amino acids, the thiol side chain in cysteine has the highest nucleophilicity; thus, assessment of intrinsic thiol group reactivity in the HTS processes is expected to accelerate drug discovery. In general, kchem (M-1s-1), the secondary reaction rate constant of a compound to thiol, can be evaluated via time course measurements of thiol-compound adducts using liquid chromatography-mass spectroscopy; this requires time-consuming and labor-intensive procedures. To overcome this issue, we developed a fluorescence-based competitive endpoint assay that allows quantitative calculation of the reaction rate of test compounds in an HTS format. Our assay is based on the competitive reaction for a free thiol (e.g., glutathione) between the test compounds and a fluorescent probe, o-maleimide BODIPY. Our assay provides robust data with a satisfactory throughput at an affordable cost. Our kchem evaluation method has advantages over previous assays in terms of higher throughput and quantitativeness. Thus, it contributes to early elimination of reactive compounds as well as quantitative evaluation of the kchem values of covalent inhibitors.

Entities:  

Keywords:  counterscreening; high-throughput screening; intrinsic chemical reactivity; irreversible inhibition; reactive compounds

Year:  2017        PMID: 28426937     DOI: 10.1177/2472555217704654

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  2 in total

1.  Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10).

Authors:  Makoto Fushimi; Hannes Buck; Melanie Balbach; Anna Gorovyy; Jacob Ferreira; Thomas Rossetti; Navpreet Kaur; Lonny R Levin; Jochen Buck; Jonathan Quast; Joop van den Heuvel; Clemens Steegborn; Efrat Finkin-Groner; Stacia Kargman; Mayako Michino; Michael A Foley; Michael Miller; Nigel J Liverton; David J Huggins; Peter T Meinke
Journal:  ACS Med Chem Lett       Date:  2021-07-14       Impact factor: 4.632

2.  2-Sulfonylpyrimidines as Privileged Warheads for the Development of S. aureus Sortase A Inhibitors.

Authors:  Fabian Barthels; Jessica Meyr; Stefan J Hammerschmidt; Tessa Marciniak; Hans-Joachim Räder; Wilma Ziebuhr; Bernd Engels; Tanja Schirmeister
Journal:  Front Mol Biosci       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.